ea0071012 | Chronic complications versus glycaemic variability, time in range and HbA1c in people with type 1 diabetes: sub study of the RESCUE-trial | BES2020
A El Malahi
, M Van Elsen
, S Charleer
, F De Ridder
, K Ledeganck
, B Keymeulen
, L Crenier
, R Radermecker
, B Lapauw
, C Vercammen
, F Nobels
, C Mathieu
, P Gillard
, C De Block
Background and aims: So far, HbA1c is the only metric of glucose control showing a strong association with chronic complications. However, it does not reflect short-term glycemic variability nor provides guidance in decreasing risk of hypoglycemia. More widespread use of continuous glucose monitoring (CGM) has changed the way people with type 1 diabetes (T1D) manage their glycemia by providing information about glycemic variability and time spent in different glucose ranges.</...